Known Alzheimer's disease genes account for only 30% of genetic activity of the disease. With 70% of the genetic component of Alzheimer's unknown, not even the best efforts can develop effective therapies to slow, stop or reverse the disease. Cure Alzheimer's Fund is going to the heart of this problem with the Alzheimer's Genome Project Intiative.
 
A+ | A- | Reset
Virginia M.-Y. Lee, Ph.D. M.B.A. Print
Photo of Virginia M.-Y. Lee, PhD MBA University of Pennsylvania
The John H. Ware III Professor in Alzheimer's Research, Dept of Pathology and Laboratory Medicine; Director, Center for Neurodegenerative Disease.

Dr. Lee is a world renowned leader in research on tau, alpha-synuclein and the beta-amyloid precursor protein, and their pathobiological roles in neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and frontotemporal dementias.  In particular, Dr. Lee is attempting to determine the pathogenic roles of the abnormal proteins comprising senile plaques, Lewy bodies, and neurofibrillary tangles, major pathological lesions found in the brains of patients with Alzheimer's disease and other neurodegenerative diseases.
 
< Prev   Next >
[ Back ]